KRTAP9-L3 Inhibitors
KRTAP9-L3 inhibitors constitute a specialized class of chemical compounds engineered to modulate the activity of Keratin-associated protein 9-like 3 (KRTAP9-L3). As a member of the keratin-associated protein family, KRTAP9-L3 is predominantly expressed in hair follicles, where it plays a pivotal role in the complex process of hair development. The inhibitors crafted for KRTAP9-L3 are meticulously designed to selectively impede the function of this protein, typically by targeting distinctive structural features or specific active sites. By disrupting KRTAP9-L3 activity, these inhibitors offer researchers a controlled means to explore the nuanced contributions of this protein to the intricate molecular dynamics underlying hair formation.
The chemical class of KRTAP9-L3 inhibitors provides a valuable toolset for investigating the fundamental processes of hair biology. Through targeted interference with KRTAP9-L3, researchers can unravel the intricacies of keratinization, shedding light on the molecular interactions and regulatory mechanisms that dictate the composition and structure of hair fibers. This focused approach allows for a more refined understanding of the specific functions attributed to KRTAP9-L3 within the broader context of hair development. The study of KRTAP9-L3 inhibitors contributes to advancing our knowledge of dermatological science, offering insights into the molecular facets that govern the remarkable complexity of hair physiology.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Sirolimus can inhibit mTOR, which is involved in cell growth and protein synthesis, possibly affecting gene expression indirectly. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits eukaryotic protein synthesis by interfering with ribosome function, which can reduce protein levels globally. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D intercalates into DNA, inhibiting RNA polymerase and preventing mRNA synthesis. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide has been shown to inhibit the transcription of a wide range of genes by affecting RNA polymerase II activity. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
α-Amanitin is a potent inhibitor of RNA polymerase II, which is responsible for mRNA synthesis. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin inhibits topoisomerase I, which can lead to DNA damage and potentially affect gene transcription. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
Flavopiridol inhibits cyclin-dependent kinases, which can alter cell cycle progression and indirectly affect gene expression. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine can raise endosomal pH and interfere with DNA replication and transcription in certain contexts. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide inhibits topoisomerase II, leading to DNA breaks that can disrupt transcription. | ||||||
Mitoxantrone | 65271-80-9 | sc-207888 | 100 mg | $285.00 | 8 | |
Mitoxantrone intercalates into DNA and inhibits topoisomerase II, affecting DNA replication and transcription processes. | ||||||